Global Cystic Fibrosis Therapeutics Analysis, Segmentation, Competitors Analysis, Product Research, Trends and Forecast by 2024

 

The Cystic Fibrosis Therapeutics Market is anticipated to grow with double digit CAGR during the forecasting period. Cystic fibrosis is among the most common life-threatening genetic disorders worldwide. It is caused by defects in a single gene known as the cystic fibrosis transmembrane conductance regulator, or CFTR. The increasing prevalence of cystic fibrosis, rising awareness about cystic fibrosis therapy, strong pipeline candidates, technological advancement and high rate of R&D initiatives are some of the major factors that are driving cystic fibrosis therapeutics market. However, high cost involved in treatment, increase in complexity of disease are restraining the cystic fibrosis therapeutics market.

Request a Sample @:  http://orbisresearch.com/contacts/request-sample/468495  

Global Cystic Fibrosis Therapeutics Market – Major Marketed Products Covered
1. Orkambi (Lumacaftor/Ivacaftor)
2. Kalydeco (Ivacaftor)
3. Cayston (Inhaled Aztreonam)
4. Pulmozyme (Dornase Alfa)
5. TOBI/ TOBI Podhaler
6. Creon
7. Zenpep
8. Ventolin
9. Bronchitol (Inhaled Mannitol)
10. ADEKplusTM
11. Ibuprofen

Global Cystic Fibrosis Therapeutics Market – Pharmacological Class
CFTR Modulators
Mucolytic Agents
Pancreatic Enzyme Replacement Products
Antibiotics
Other Therapies

Cystic Fibrosis Therapeutics Market – Geographical Analysis
1. United States
2. Canada
3. France
4. Germany
5. Italy
6. Spain
7. United Kingdom
8. Australia
9. Japan
10. China
11. India
12. South Korea

Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis
1. Genentech, Inc. (A Member of the Roche Group)
2. Novartis
3. Gilead Sciences, Inc.
4. Vertex Pharmaceuticals Incorporated
5. AbbVie
6. GlaxoSmithKline
7. Johnson & Johnson
8. Allergan plc
9. Pharmaxis Ltd
10. Mylan N.V

 Make an enquiry before buying this report : http://orbisresearch.com/contacts/enquiry-before-buying/468495   

Some of the Points cover in Report “Cystic Fibrosis Therapeutics Market (By Major Marketed Products, Pharmacological Class, and Geography) and Pipeline Analysis-Global Forecast to 2024” is:

  1. Executive Summary
  2. Global Cystic Fibrosis Therapeutics Market & Forecast (2014 – 2024)
  3. Global Cystic Fibrosis Therapeutics Market Share & Forecast
    3.1 By Geography – Cystic Fibrosis Therapeutics Market Share & Forecast (2014 – 2024)
    3.2 By Pharmacological Class – Cystic Fibrosis Therapeutics Market Share & Forecast (2015 – 2021)
  4. Global Cystic Fibrosis Therapeutics Market – Major Marketed Products Sales & Forecast
    4.1 Orkambi (Lumacaftor/Ivacaftor) Sales & Forecast (2015 – 2021)
    4.2 Kalydeco (Ivacaftor) Sales & Forecast (2012 – 2021)
    4.3 Cayston (Inhaled Aztreonam) Sales & Forecast (2010 – 2021)
    4.4 Pulmozyme (Dornase Alfa) Sales & Forecast (2012 – 2021)
    4.5 TOBI/ TOBI Podhaler Sales (2012 – 2016)
    4.6 Creon Sales & Forecast (2011 – 2021)
    4.7 Zenpep Sales & Forecast (2014 – 2021)
    4.8 Ventolin Sales & Forecast (2012 – 2021)
    4.9 Bronchitol (Inhaled Mannitol) Sales & Forecast (2013 – 2021)
    4.10 ADEKplusTM
    4.11 Ibuprofen
  5. Global Cystic Fibrosis Therapeutics Market – Pharmacological Class Sales & Forecast (2015 – 2021) 
    5.1 CFTR Modulators Sales & Forecast
    5.2 Mucolytic Agents Sales & Forecast
    5.3 Pancreatic Enzyme Replacement Products Sales & Forecast
    5.4 Antibiotics Sales & Forecast
    5.5 Other Therapies Sales & Forecast
  6. By Geography – Cystic Fibrosis Therapeutics Market (2014 – 2024) 
  7. Global Cystic Fibrosis Pipeline Product Analysis – By Company & Phase of Development
  8. Cystic Fibrosis Company Profiles, Approved & Pipeline Product Analysis
    8.1 Genentech, Inc. (A Member of the Roche Group)
    8.2 Novartis
    8.3 Gilead Sciences, Inc.
    8.4 Vertex Pharmaceuticals Incorporated
    8.5 AbbVie
    8.6 GlaxoSmithKline
    8.7 Johnson & Johnson
    8.8 Allergan plc
    8.9 Pharmaxis Ltd
    8.10 Mylan N.V.
  9. Global Cystic Fibrosis Market – Industry Trends & Developments
    9.1 Genetic Testing
    9.2 Technological Advances
    9.3 CFTR Modulators – Gaining Momentum
    9.4 Upsurge in the Number of Strategic Collaborations
    9.5 Combination Therapy
    9.6 Co-pay and Assistance Programs by Vendors
    9.7 Increased R&D Activities: Drives Market Growth
  10. Global Cystic Fibrosis Market – Growth Drivers
    10.1 Robust Pipeline
    10.2 Increasing Prevalence of Cystic Fibrosis
    10.3 Improvement in Diagnostic Technologies
    10.4 Unmet Medical Needs
  11. Global Cystic Fibrosis Market – Challenges

Browse the Full Report@ : http://orbisresearch.com/reports/index/cystic-fibrosis-therapeutics-market-by-major-marketed-products-pharmacological-class-and-geography-and-pipeline-analysis-global-forecast-to-2024

 About Us:

Orbis Research (orbisresearch.com) is a single point aid for all your market research requirements. We have vast database of reports from the leading publishers and authors across the globe. We specialize in delivering customized reports as per the requirements of our clients. We have complete information about our publishers and hence are sure about the accuracy of the industries and verticals of their specialization. This helps our clients to map their needs and we produce the perfect required market research study for our clients.